Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on new insulins].

J C Philips1, R Radermecker

  • 1Service de diabétologie, nutrition et maladies métaboliques, Département de médecine, CHU Sart Tilman, 4000 Liege I, Belgique. jcphilips@ulg.ac.be

Revue Medicale Suisse
|October 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nasal glucagon (Baqsimi®), new treatment for hypoglycaemic coma].

Revue medicale de Liege·2022
Same author

[Gestational diabetes mellitus : prelude of risks not to be misunderstood].

Revue medicale de Liege·2022
Same author

[Crossed eyes on arterial blood pressure in sitting position].

Revue medicale de Liege·2021
Same author

[Ultra-rapid lispro (Lyumjev®)].

Revue medicale de Liege·2021
Same author

[Therapeutic and technological advances in the management of adult patients with type 1 diabetes].

Revue medicale de Liege·2020
Same author

[Pathologies of the musculoskeletal system in diabetes mellitus].

Revue medicale de Liege·2019
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
See all related articles

New insulin analogues improve diabetes management by mimicking natural insulin secretion. These advanced formulations reduce hypoglycemia risk and enhance patient quality of life.

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology

Context:

  • Optimal diabetes mellitus management necessitates insulin formulations that mimic physiological insulin secretion.
  • Advances in biotechnology have enabled the development of novel insulin analogues through targeted amino acid substitutions.

Purpose:

  • To review the pharmacokinetic and pharmacodynamic properties of new insulin analogues.
  • To assess the clinical benefits and practical advantages of these advanced insulin formulations.

Summary:

  • Insulin analogues offer improved pharmacokinetic profiles compared to traditional insulins.
  • Ultra-short and long-acting insulin analogues have been developed, enhancing basal and postprandial insulin coverage.
  • While not drastically lowering glycated hemoglobin, these analogues significantly reduce hypoglycemia incidence.

Related Experiment Videos

Impact:

  • These insulin analogues provide practical advantages, potentially improving the quality of life for diabetic patients.
  • The development represents a significant step forward in personalized diabetes therapy.